Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the
enzymes needed for cell growth. Drugs used in chemotherapy, such as capecitabine, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Giving lapatinib ditosylate together with capecitabine may kill more
tumor cells.
PURPOSE: This phase II trial is studying how well giving lapatinib ditosylate together with
capecitabine works in treating patients with metastatic pancreatic cancer.